Body Vision Medical, a leader in AI-driven intraoperative imaging, and Mediflex, a leading developer and producer of unique, innovative surgical devices have entered into a distribution agreement that enables Body Vision to sell Mediflex’s Bronchoscope Stabilization System (BSS) product globally.
The agreement expands bronchoscopists’ access to Mediflex’s BSS globally while simultaneously enabling Body Vision to offer a world-class product synergistic to its LungVision™ AI-powered image guidance platform to its rapidly expanding global customer base.
“This is a great opportunity for Mediflex to partner with a global leader aligned with our target market for our BSS product,” said Mediflex President, Jonathan Adler. “Body Vision’s global distribution infrastructure into interventional pulmonology better positions Mediflex to bring our unique BSS product offering to the customers who would best benefit from it as well as rapidly grow our presence in this segment.”
“Body Vision Medical is committed to offering our customers compelling and innovative products that help them achieve the quintuple aim of healthcare,” said David Webster, CEO of Body Vision Medical. “We feel strongly that this partnership to distribute Mediflex’s BSS will not only reinforce our global presence but also provide significant value to our customers.”
This global distribution agreement is effective immediately.
Body Vision Medical specializes in AI-driven, intraoperative imaging with the aim of saving lives through the democratization of innovative medical technology. Its first commercial product, LungVision, addresses the unmet clinical need for early, definitive lung cancer diagnosis and, in the future, to enable effective treatment of lung lesions via a minimally-invasive procedure.
SOURCE: Prnewswire